Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells
2004 · Breast Cancer Research · 75 citations
https://doi.org/10.1186/bcr918
A
Andrew W. Hutcheon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
5.1K
Citations
32
h-index
59
i10-index
Andrew W. Hutcheon is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & Breast Lesions and Carcinomas. The author has an h-index of 32, co-authored 82 publications.
Papers by this author
worksCommon, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
2021 · Human Genetics · 39 citations
https://doi.org/10.1007/s00439-021-02397-7
A phase II study of mitomycin C, cisplatin and continuous infusion 5-fluorouracil (MCF) in the treatment of patients with carcinoma of unknown primary site
2002 · British Journal of Cancer · 23 citations
https://doi.org/10.1038/sj.bjc.6600258
Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
2004 · British Journal of Cancer · 10 citations
https://doi.org/10.1038/sj.bjc.6601528
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat